ThursdayFeb 15, 2024 9:45 am

New England Cannabis Convention To Be Held In Boston, MA

Businesses, leaders, enthusiasts, and service providers of the cannabis spectrum are all invited to the NECANN Boston Convention, the 2nd largest B2B cannabis industry event across the globe. Since its 70th booth convention back in 2015, NECANN has come a long way. This year’s convention will feature over 350 exhibitors, several workshops, five full programming tracks, and a day-long financial/investor summit. The age limit to attend the conference is 18+ unless accompanied by a guardian. The NECANN event is a phenomenal business platform attracting the New England cannabis trading community and other visitors. Influential cannabis industry leaders will be at…

Continue Reading

WednesdayFeb 14, 2024 9:45 am

Turbo Energy (NASDAQ: TURB) Drives AI Innovation within Residential Energy Storage Solutions

Artificial Intelligence is expected to both, drive global energy consumption whilst simultaneously, increasing the efficiency of global power usage Turbo Energy is seeking to harness artificial intelligence in the manufacture and development of their residential energy solutions, which allow households to capture and store solar energy The Company has recently entered into an agreement with Solar360, the energy-focused subsidiary of Repsol and Telefonica, in a move to dramatically increase their distribution footprint The growing demands of artificial intelligence (“AI”) are set to drive a sharp increase in data center storage capacity, with the latter expected to grow from 10.1 zettabytes…

Continue Reading

WednesdayFeb 14, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks off 2024 with FDA IND Submission for its HYPER-H23-1 Phase 1b Human Clinical Trial

Lexaria, a global innovator in drug delivery platforms, just announced the submission of its IND application with the FDA for its HYPER-H23-1 phase 1b hypertension clinical trial This study will seek to evaluate the safety and tolerability of Lexaria’s patented DehydraTECH(TM) technology, specifically DehydraTECH-CBD, in hypertensive patients Lexaria expects to build on success of its previous studies, which showed positive results and DehydraTECH-CBD’s potential to have broad therapeutic utility Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the submission of its much-anticipated Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”)…

Continue Reading

TuesdayFeb 13, 2024 9:45 am

GEMXX Corp. (GEMZ) Anticipates Significant Growth over the Next 24 Months on ‘Tremendous Potential’ in Ammolite and Gold Markets

GEMXX expects the growing demand for Ammolite, coupled with the positive outlook for gold prices, to support significant growth over the next 24 months Last year, GEMXX moved to complement its Ammolite operations with the purchase of gold assets in Canada The price of gold has held steady above US$2,000 per ounce, coming off a record-breaking 2023 when it rallied to a record-high year-end close The future looks promising for gold because it is projected to reach new highs in the coming months, according to GEMXX The price of an ounce of gold rallied to a record high year-end close…

Continue Reading

TuesdayFeb 13, 2024 9:00 am

Clene Inc. (NASDAQ: CLNN) Revolutionizes Approach to Restore Neuronal Health in Neurodegenerative Disease with CNM-Au8(R)

Neurodegenerative diseases pose a significant challenge in healthcare, yet treatment options remain limited CNM-Au8(R) has demonstrated remarkable efficacy across various nervous system cell types, with its ability to target fundamental deficiencies associated with dying neurons Gold nanocrystals found in CNM-Au8 act as miniature mitochondria, providing neurons with much-needed ATP energy while simultaneously converting toxic reactive oxygen species into harmless compounds Neurodegenerative diseases pose a significant challenge in healthcare, yet treatment options remain limited. Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, is working on a potentially groundbreaking…

Continue Reading

MondayFeb 12, 2024 10:30 am

Sustain SoCal Sustainable Agriculture and Food Systems 2024 – Presents Latest Ag and Food Systems Developments

Sustain SoCal invites regional leaders, regulatory authorities, individuals, and entities in the food and agriculture spectrum, to gather at the Sustainable Agriculture and Food Systems Event on February 20, 2024, and share their journeys, achievements, failures, and shortfalls in the existing system. With seven years in the agricultural space, the event will be attended by top industry leaders, entrepreneurs, and investors in Southern California. For companies looking to maximize their visibility in a crowd of agriculture and food leaders, this Sustain SoCal event offers the perfect avenue. A variety of packages are available to fit every company’s needs that would…

Continue Reading

MondayFeb 12, 2024 9:45 am

SOBRsafe Inc. (NASDAQ: SOBR) Announces SOBRsure(TM) Sales Activities in Australia and New Zealand

SOBRsure sales activities in Australia and New Zealand have been initiated through an international channel partnership with Drug Testing Business Success Drug Testing Business Success has a 14-year history representing the world's most widely-used ankle bracelet for alcohol detection The global alcohol sensor market was valued at $2.3 billion in 2022, and is expected to reach $6.3 billion by 2030 SOBRsafe's products are geared toward behavioral health, justice, and consumer markets – and well-positioned for licensing and integration SOBRsafe (NASDAQ: SOBR), a provider of next-generation transdermal alcohol detection solutions, recently announced that it has initiated SOBRsure(TM) sales activities in Australia…

Continue Reading

MondayFeb 12, 2024 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) CEO, Chris Bunka, Shares 2023 Company Update and 2024 Roadmap in Annual Letter

Lexaria, a global innovator in drug delivery platforms, just announced ambitious plans for the 2024 calendar year The letter confirms that the 2024 plans have been made possible by significant strides that were made by the company in 2023 Lexaria looks to build on the momentum gained from the previous year, ultimately asserting market dominance and making 2024 its best year yet Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its ambitious plans for the 2024 calendar year. In his annual letter, Chris Bunka, Lexaria’s CEO, noted that this would mark the year that will…

Continue Reading

FridayFeb 09, 2024 10:30 am

China Rare Earths ‘Crisis’ Spells BIG Opportunity

We’ve known this was coming, for a very long time. For well over a decade, various experts have been warning governments and industry about global over-reliance on China for the supply of rare earth elements (REE). Now, this day of reckoning has arrived. Beginning in the spring of 2023, China first “threatened” to impose restrictions on the export of some rare earths. Just recently, China passed a law that could reduce its exports of critical REE. However, you don’t have to be Chinese to see “crisis” and “opportunity” as being two sides of the same coin. Fortunately, a number of…

Continue Reading

FridayFeb 09, 2024 9:00 am

Electronic Servitor Publication Network Inc. (XESP) Combines Powerful Digital Engagement Engine(TM) with Simple Pricing Model to Drive Growth of Client Companies

Electronic Servitor Publication Network provides the Digital Engagement Engine(TM), a sophisticated technology stack that helps businesses fully engage target audiences more efficiently, moving audiences from awareness to action, thereby driving growth The Digital Engagement Engine(TM) is digitally transforming content marketing by solving deficiencies through a higher level of sophisticated automation The technology offers numerous benefits, including enabling client companies to target their leads with greater accuracy, dynamically delivering provisioned content, and heightening the effectiveness of content marketing XESP uses a pricing model that lowers the barrier to entry, allowing more customers to harness the benefits of its superior technology stack…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered